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ABSTRACT 
Although numerous materials have been explored as bone scaffolds, many of them are limited by 
their low osteoconductivity and a high biodegradability. Therefore, new materials are desired to 
induce bone cell proliferation and facilitate the bone formation. Attapulgite (ATP) is a hydrated silicate 
that exists in nature as a fibrillar clay mineral and is well known for its large specific surface area, 
high viscosity, and high absorption capacity, therefore has the potential to be a new type of bone 
repair material due to its unique physicochemical properties. In this study, composite scaffolds 
composed of collagen/polycaprolactone/attapulgite (CPA) or collagen/polycaprolactone (CP) were 
fabricated through aVDOWOHDFKLQJPHWKRG. The morphology, composition, microstructure, physical 
and PHFKDQLFDO characteristics of the CPA and CP scaffolds were assessed. Cells from the mouse 
multipotent mesenchymal precursor cellOLQH'FHOOVZHUHFRFXOWXUHGZLWKWKHVFDIIROGVDQGcell 
DGKHVLRQ, proliferation, and gene expression on the CPA and CP scaffolds were analyzed.$GXOW
UDEELWVZLWKUDGLXVGHIHFWVZHUHused to evaluate the SHUIRUPDQFHRIWKHVHVFDIIROGVLQUHSDLULQJWKH
ERQH GHIHFWV RYHU  WR ZHHNV7KH experimental results showed that the cells demonstrated 
excellent attachment ability on the CPA scaffolds, as well as remarkable upregulation of the levels 
of osteoblastic markers such as Runx2, Osterix, collagen 1, RVWHRSRQWLQ, and RVWHRFDOFLQ. 
Furthermore, results from radiography, micro-computed tomography, histological and 
LPPXQRKLVWRFKHPLFDO analysis GHPRQVWUDWHG that abundant new bones were formed on the CPA 
scaffolds. Ultimately, these results demonstrated that CPA composite scaffolds have excellent 
capability in bone tissue engineering applications and have the potential to be used as effective bone 
regeneration and repair scaffolds in clinical applications. 
KEYWORDS:Attapulgite Polycaprolactone, Collagen 1, CRPSRVLWHVFDIIROG Bone regeneration, 
Mouse multipotent mesenchymal precursor cell line D1   
 
1. ,1752'8&7,21 
Repairing bone defects caused by bone tumor resections, fracture defects, or chronic infection is still 
challenging in orthopedic practice1-3.$utograft is the gold-standard approach in current bone repair. 
However, WKLV WHFKQLTXH has several disadvantages, including limited supply of bone tissue, 
induction of new trauma, and the potential for functional damage4, 5.$llografts are also used clinically 
because of the availability in bone tissue supply, but tKHVHJUDIWVFDUU\WKHULVNRIinfection, disease 
transmission, and the induction of immune response6-8. Advances in bone tissue engineering (BTE) 
have the potential to address these challenges and promote bone regeneration and repair9-12. 
However, fabricating 3D porous scaffolds for cell migration, proliferation, differentiation, and nutrient 
delivery is challenging. 
An ideal scaffold for BTE should have LH[FHOOHQWPHFKDQLFDOSURSHUWLHVWRHQDEOHWKHERQHWLVVXH
UHPRGHOLQJLLH[FHOOHQWELRFRPSDWLELOLW\WRIDFLOLWDWHFHOODWWDFKPHQWDQGSUROLIHUDWLRQLLLDSSURSULDWH
ELRGHJUDGDELOLW\ZLWKFRQWUROODEOHGHJUDGDWLRQDQGUHVRUSWLRQUDWHVWRPDWFKWKHERQHUHJHQHUDWLRQ
 
  
LLLLDSSURSULDWHSRURVLW\IRUFHOOVWRDWWDFKPLJUDWHSUROLIHUDWHDQGGHSRVLWH[WUDFHOOXODUPDWUL[(&0
,QWHUFRQQHFWLRQRISRUHVLVDOVRUHTXLUHGWRDOORZWKHWUDQVSRUWDWLRQRIQXWULHQWVPHWDEROLWHVDQG
ZDVWHSURGXFWVUHPRYDO 
In general, three types of bone scaffold materials have been explored in the past: bioactive 
ceramics, biodegradable metals and biodegradable polymers. Bioactive ceramics such as calcium 
phosphate (CaP) ceramics, including hydroxyapatite (HA) and tricalcium phosphate (TCP) have 
similar compositions to natural bone. These materials have good biocompatibility and 
osteoconductivity. The degradation of these materials releases ions that can enhance the cell activity 
and facilitate the bone repair. However, bioactive ceramics have low toughness and insufficient 
strength, therefore are not ideal to be used without the addition of other materials1. For example, HA 
is one of the major constituents of natural bone, DFFRXQWLQJIRUE\ZHLJKWRIKXPDQERQH. 
HA material is biocompatible, osteoconductive, noncytotoxic, and nonimmunogenic and has a slow 
degradation rate17-19. Therefore, it has been widely used in BTE5, 20. However, HA is fragile, inflexible, 
and is difficult to model, limiting its application in bone regeneration and repair17, 21. Calcium 
phosphate (CaP) bioceramics have also been successfully applied in hard tissue regeneration as a 
gold standard. These bioceramics exhibit excellent biocompatibility and chemical similarity with hard 
tissues. Therefore, they have been extensively used in clinical repair of bone defects. Recently 
additive manufacturing has been employed for the fabrication of bioceramic scaffolds in addition to 
those traditional methods such as solvent casting, freeze drying, phase separation etc. However, 
due to their brittleness, poor mechanical properties and lack of other valuable trace metal ions (e.g. 
Si4+, Sr2+, and Mg2+), these materials are only limited to the defects of non-load-bearing bone. To 
improve the mechanical properties, osteoconductivity, osteogenic ability and printability of the CaP 
bioceramics, inorganic and organic materials have to be incorporated with CaP bioceramics 22.In 
contrast, biodegradable metals such as Mg, Zn, Fe, and their alloys have better toughness and 
processability than bioactive ceramics. However, biodegradable metals have a fast degradation 
process. The rapid degradation leads to the quick loss of mechanical integrity and stability1. Polymer 
materials are the most extensively used materials for BTE. So far, a considerable number of polymer 
materials such as polycaprolactone (PCL), SRO\/ODFWLF $FLG 3//$ SRO\JO\FROLF DFLG 3*$
SRO\ODFWLF DFLG 3/$ DQG SRO\ ODFWLFFRJO\FROLF DFLG 3/*$ have been developed for bone 
regeneration23-29 due to their wide availability, and good mechanical properties. However, synthetic 
polymers are lack of bioactivity, cell affinity, and hydrophilicity1. Therefore, the three types of bone 
materials each has its advantages and disadvantages. Composite scaffolds made from the above 
materials combine their advantages and eliminate their shortcomes providing improved properties 
for BTE. Bioactive ceramics or biodegradable metals provide osteoconductivity, mechanical strength 
and the minerals required for BTE. Polymers can be used as binders to UHLQIRUFHWKHPHFKDQLFDO
SURSHUW\ RI bioactive ceramics and biodegradable metals DQG KHOSPRGHO WKH DUFKLWHFWXUH )RU
H[DPSOH Fhitosan has been used to make composite scaffolds with nanohydroxyapatite. It was 
found that the compression modulus increased with the amount of nanohydroxyapatite. The 
composite scaffolds were found superior in terms of cell attachment, proliferation, and morphology 
in relation to chitosan scaffold31. 3/*$DQG3&/KDYHDOVREHHQZLGHO\XVHGDVDbinder for HA in 
the past decades with PCL based composites attracted more attention than other synthetic polymer 
composites2, 15, 31, 32. For example, composite scaffolds made from PCL and oyster shell powder 
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showed Improved crystallinity and mineralization ability for BTE application33. PCL has also been 
combined with octacalcium phosphate to fabricate electrospun scaffolds for BTE32. Enhanced 
performance of osteoblast human G-292 cells on the scaffolds was observed.  
While a number of excellent polymers are available, the numbers of excellent bioactive ceramics are 
much less. $WWDSXOJLWH $73 LV D QDWXUDO FOD\ PLQHUDO WKDW KDV EHHQ XVHG LQ WKH environmental 
industry asDQDGVRUEHQWDVDGHFRORUL]LQJDJHQWDQGIRUFDWDO\VWVXSSRUWATP is composed 
of SiO2 (55.03%), Al2O3 (10.24%), MgO (10.49%), Fe2O3 (3.53%), H2O+ (10.13%), and H2Oí 
(9.73%)37-39, and is well known for its porosity, large specific surface area, high viscosity, and 
absorption ability. It possesses the physical properties as well as the minerals desired for BTE. 
Recently, it has been reported that electrospun ATP/PLGA nanofibers promote the differentiation of 
human mesenchymal stem cells into osteoblasts40, making ATP a promising VFDIIROGPDWHULDO IRU
%7(&RPELQLQJWKHDGYDQWDJHVRI$73DQGSRO\PHUVZLOOSURYLGHDQHZVWUDWHJ\IRULPSURYHGERQH
UHJHQHUDWLRQ +RZHYHUWKHXVHRI$73DVERQHWLVVXHHQJLQHHULQJIRUERQHUHSDLULVRQO\HPHUJLQJ
)XUWKHUVWXGLHVDUHUHTXLUHGWRRSWLPL]HLWVDSSOLFDWLRQVLQ%7(  
In this study, collagen (type 1)/polycaprolactone/attapulgite (COL1/PCL/ATP) composite scaffolds 
were fabricated for the BTE. Collagen is an extracellular matrix (ECM) protein of the main tissues 
(skin, blood vessels, and bone) 41, 42. Scaffold manufactured with collagen has excellent 
biocompatibility and biodegradability43. Collagen is often cross-linked by physical and chemical 
methods using ultraviolet light, glutaraldehyde, or genipin7, 44 to increase its mechanical properties. 
PCL has been widely used in UHJHQHUDWLYHPHGLFLQHEHFDXVHRILWVJRRG biocompatibility, elasticity 
and low immunogenic response2, 18The purpose of this study was to compare a COL1/PCL/ATP 
(CPA) scaffold with a COL1/PCL (CP) scaffold to find out whether the addition of ATP can improve 
the differentiation of bone marrow±derived stroma cells into RVWHREODVWFHOOV, thus promoting bone 
regeneration. The scaffolds were made through VDOWOHDFKLQJPHWKRGDVillustrated in the ToC figure 
and were characterized by a combination of SEM, FTIR and mechanism tests. The HOHPHQWDO
FRPSRVLWLRQ porosity, water absorption, contact angle, and degradation were investigated. Cell 
proliferation and morphology on the scaffolds, as well as the expression of bone regeneration related 
proteins such as Runx2, Osterix, alkaline phosphatase (ALP), collagen 1 (COL1), osteocalcin (OC), 
and osteopontin (OPN) were studied. The scaffolds were implanted into bone defects using rabbit 
model. Radiography, micro-CT Scan, histological and immunohistochemical staining were used to 
evaluate the in vivo bone regeneration. The current study demonstrated that CPA composite 
scaffolds have great potential in BTE applications.    
 
2. MATERIALS AND METHODS 
2.1 Preparation of CP and CPA Scaffolds 
7KHSRURXVF\OLQGULFDO&3DQG&3$VFDIIROGVZHUHIDEULFDWHGXVLQJDVDOWOHDFKLQJPHWKRG%ULHIO\
FROODJHQ W\SH  &2/ ZDV GLVVROYHG LQ KH[DIOXRURLVRSURSDQRO +)/3 WR REWDLQ DQ  ZY
 
  
XQLIRUPVROXWLRQ3&/SRO\PHUSRZGHU6LJPD$OGULFK86$ZDVWKHQDGGHGWR WKHVROXWLRQZLWK
PDJQHWLFVWLUULQJXQWLODKRPRJHQHRXVVROXWLRQZDVIRUPHG7KHUDWLRRI&2/3&/ZDVZZ
9DULRXVYROXPHVRIQDQRVL]HG$73QP/DQ]KRX,QVWLWXWHRI&KHPLFDO3K\VLFV&KLQHVH
$FDGHP\ RI 6FLHQFHV SRZHU DQG VRGLXP FKORULGH SDUWLFOHV  ȝP 6KDQJKDL Chemical 
Industry&KLQDZHUHPL[HGZLWK WKHVROXWLRQ WR IRUPSDVWHVZLWK$73FRQFHQWUDWLRQVRI&3
VFDIIROG &2/3&/$73 PDVV UDWLR RI   &3$ORZ GRVH >&3$/@ VFDIIROG
&2/3&/$73PDVVUDWLRRIDQG&3$KLJKGRVH>&3$+@VFDIIROG&2/3&/$73
PDVVUDWLRRI7KHSDVWHVZHUHWKHQSODFHGLQWRPROGVWKDWZHUHPPLQOHQJWKDQG
PPLQGLDPHWHU7KHPROGVZHUHOHIWLQWKHGU\LQJRYHQIRUKDQGWKH+)/3ZDVFRPSOHWHO\
HYDSRUDWHGLQDvacuum condition untilFLUFXODUF\OLQGHUVKDGIRUPHG7KHUHVXOWLQJKLJKO\SRURXV&3
DQG&3$VFDIIROGVKDGOHQJWKVRIWRPPDQGGLDPHWHURIPP7KHVFDIIROGVZHUHWKHQSODFHG
LQWRGHLRQL]HG',ZDWHUIRUKWRHOXWHDOOWKHsodium chloride. Samples were then tested with 
$J12WRFRQIRUPWKHFRPSOHWHUHPRYDORI1D&O  
EDC/NHS (in ethanol: water at 80:20 v/v) were used to crosslink the CP and CPA scaffolds. The air-
dried scaffolds were placed in 250 mM EDC/NHS solution for 24 hDWURRPWHPSHUDWXUH before rinsing 
3 times with ', water to remove the residual EDC/NHS. After which the scaffolds were dried DWURRP
WHPSHUDWXUH. Each scaffold was cut ZLWKDVXUJLFDONQLIHEODGH to PP in diameterDQGPP in 
lengthVHDOHGDQGVWHULOL]HGZLWK&R 
2.2 Scanning Electron Microscopy 
$WWDSXOJLWH (ATP): 7KHPRUSKRORJ\DQGPLQHUDO FRQWHQWRI WKH$73ZHUH LQYHVWLJDWHGXVLQJ WKH
VFDQQLQJHOHFWURQPLFURVFRS\6(0Hitachi61V\VWHPJapan)$73ZDVGHSRVLWHGRQWRD
FDUERQFRDWHGFRSSHUJULGDQGFRDWHGZLWKJROGIRUKEHIRUHREVHUYDWLRQ6L[VDPSOHVZHUHWHVWHG
ZLWKWLPHVIRUHDFKVDPSOH  
CP and CPA Scaffolds: SEM (JHitachi S 3400N, Japan) was used to observe the interconnected 
porous structure and composition of the scaffolds. Before observation, scaffolds stored in 100% 
ethanol were dried by supercritical carbon dioxide. 
2.3 Water Absorption, Porosity, Contact Angles, and 'HJUDGDWLRQ of Scaffolds 
The water absorption capacities of the CP and CPA scaffolds were determined by swelling the 
scaffolds in 0.2 M PBS at 37°C ( pH = 7.4). The scaffolds were cut into 10 mm in length and 4 mm in 
diameter, and separately immersed into 0.2 M PBS solution for 5 min and then for 1, 2, 3, 4, 5, 6, 
24, 48, and 72 h. The water in each scaffold was then removed and weighed. The water absorption 
ratio was obtained with the following equation:  
Water absorption ratio (%) = ௐಹିௐವௐವ ൈ ͳͲͲΨ
 
 
where WH isWKHweight of the soaked scaffold and WD is the weight of the dry scaffold.  
)RUDVVHVVPHQWRIVFDIIROGSRURVLW\F\OLQGULFDOVDPSOHVZHUHcut into 2 mm in length and 4 mm in 
diameter pieces7KHSRURVLW\RIthe VFDIIROGVZDVPHDVXUHGEDVHGRQJUDYLPHWU\DFFRUGLQJWRthe 
 
  
following equation:  
Porosity (%) = ெమିெయିெೄெభିெయ ൈ ͳͲͲΨ 
where M1 is WKHLQLWLDO PDVV of a density bottle filled with ethanol, Ms is the PDVV of the dry scaffold, 
M2 is the PDVV of the scaffoldVXEPHUJHG LQDEVROXWH ethanol with the density bottle, and M3 is the 
PDVV of the density bottle after the scaffold was JHQWO\ removed.  
The contact angle measurement of the scaffolds was carried out with a contact angle analyzer 
()7$)LUVW7HQ$QJVWURPV3RUWVPRXWK9$86$). The scaffolds were cut into 1 cm2 square 
pieces (N = 4) and then placed on a testing plate. Subsequently, 0.01 mL of DI water was carefully 
dropped onto the test sample surface. After 10 seconds, the contact angles were recorded by video 
monitor.  
)RU DVVHVVPHQW RI VFDIIROG GHJUDGDWLRQ F\OLQGULFDO VDPSOHV ZHUH FXW LQWR  PP OHQJWKV 7KH
VDPSOHVZHUHSODFHGLQWRYLDOVFRQWDLQLQJP/3%6S+ 0DQGWKHVHYLDOVZHUHSODFHG
LQWRDVKDNLQJEDWK°&IRUWRZHHNV7KH3%6VROXWLRQZDVH[FKDQJHGZHHNO\7KHORVVLQ
PDVVRIWKHVFDIIROGVZDVWKHQcalculatedXVLQJWKHIROORZLQJequation: 
:HLJKWORVW  ெబିெವெబ ൈ ͳͲͲΨ 
ZKHUH0LVWKHLQLWLDOGU\ZHLJKWRIWKHVFDIIROGDQG0'LVWKHGU\ZHLJKWDIWHUGHJUDGDWLRQ 
2.4 Fourier transform infrared spectroscopy (FTIR) 
)RXULHUWUDQVIRUPLQIUDUHGVSHFWURVFRS\3HUNLQ(OPHUVHULHV86$ZDVXVHGWRHYDOXDWHWKH
functional groups of the scaffolds. Before testing, DWRWDORIPJGULHG&3RU&3$VFDIIROGSRZGHU
ZDVPL[HGZLWKPJ.%UDQGFRPSUHVVHGLQWRDGLVN$OOVSHFWUDZHUHREWDLQHGEHWZHHQ
DQGFPDWDFPUHVROXWLRQZLWKVFDQV6L[VDPSOHVZHUHH[DPLQHGIRUWLPHVHDFK 
0HFKDQLFDO7HVWLQJ 
%HIRUHWHVWLQJWKHVFDIIROGVZHUHFXWVRWKDWWKHJDXJHOHQJWKDQGGLDPHWHURIDOOVSHFLPHQVZHUH
PPDQGPPUHVSHFWLYHO\)RUDVVHVVPHQWRIIOH[XUDOVWUHQJWKWKHVFDIIROGVZHUHWHVWHGZLWKD
SRLQWEHQGWHVWRQDQ,QVWURQXQLYHUVDOWHVWLQJPDFKLQH,QVWURQ3W\/WG1RUZRRG0$86$
DWDUDWHRIPPPLQ&RPSUHVVLYHWHVWVZHUHSHUIRUPHGRQGU\DQGZHWVFDIIROG$IWHULPPHUVLRQ
LQWKH03%6S+ IRUGD\VVDPSOHVXVLQJDXQLYHUVDOWHVWLQJPDFKLQHZLWKDN1ORDG
FHOOSpecimensZHUHFRPSUHVVHGWRof their total height at a rate of 2 mm/min WRREWDLQWKH
ORDGGLVSODFHPHQWFXUYHStress-strain graphs were then drawnDFFRUGLQJWRWKHORDGGHIRUPDWLRQ
GDWD  
2.6 Cell Culture and Seeding on Scaffolds  
&HOOV IURPWKH'mouse multipotent mesenchymal precursor cell OLQHCRL-12424ATCC, USA
ZHUHFXOWXUHGLQDMEM/F12 (Gibco, USA) supplemented with 10% fetal calf serum (FCS) and 1% 
penicillin/streptomycin at & and &2 The scaffolds were sterilized with 70% ethanol for 1 h 
 
  
and then rinsed 3 times with sterile PBS before the cells were loaded. The scaffolds were soaked in 
the DMEM/F12 medium overnight. Cells (15 µL, approximately 1.6 × 105 cells/mL) were seeded on 
both sides of the scaffold with a 2 h incubation step between additional seedings.7KHFHOOVHHGHG
VFDIIROGVZere then placed into new 24-well plates containing 1 mL of DMEM/F12 complete medium. 
The plates were incubated at 37°C with 5% CO2DQGZHUHcultured for 7 to 21 days. During this 
period, the medium was changed twice weekly. At the desired time points, the cell-VHHGHG scaffolds 
were removed from the medium and analyzed for cell adhesion, proliferation, and expression of 
osteoblast-related genes. 
2.7 Cell Proliferation and Morphology 
Cell proliferation was measured using the Cell Counting Kit-8 (CCK-8; Promega, USA). In brief, the 
cell-VHHGHG scaffold was removed from the original medium and placed into new cell culture plates 
after 1 to 7 days of culture. A total of 1 mL of medium containing 100 µL CCK-8 was added into each 
well, and the plates were incubated at 37°C for 3 h. A total of 200 µL supernatant was then removed 
from each well to a new 96-well plate and tested for absorbance at 490 nm using a plate reader 
(BIOTEK, USA). Six parallel samples from each group were analyzed, and each test was run in 
triplicate. DMEM/F12 containing 100 µL CCK-8 was used as a control.  
7KHPLFURVWUXFWXUHV of the scaffoldsDQGWKHFHOOVHHGHGVFDIIROGVZHUHDVVHVVHGXVLQJSEMJSM-
5800LV). At day 3 and 7, the cell-seeded scaffolds were fixed in 2.5% JOXWDUDOGHK\GHLQ3%6IRU
DGGLWLRQDO GD\V 7KH VDPSOHV ZHUH WKHQ GHK\GUDWHG WKURXJK D VHULHV RI DOFRKRO ZLWK GLIIHUHQW
FRQFHQWUDWLRQVIROORZHGE\GU\LQJZLWKVXSHUFULWLFDOFDUERQ
GLR[LGH Samples were sputter coated with gold for  PLQ EHIRUH WKH 6(0 PHDVXUHPHQW &HOO
PRUSKRORJ\DWWDFKPHQWRQVFDIIROGVDQGFHOOGHQVLW\ZHUHDVVHVVHGUHVSHFWLYHO\ 
2.8 Fluorescence Staining 
At day 7, the cell-seeded scaffolds were rinsed in 0. 2 M PBS and fixed in 10% IRUPDOGHK\GHIRU
DGGLWLRQDOGD\V$IWHUGHK\GUDWLRQWKHVFDIIROGVZHUHembedded in paraffin, and 5 µm sections were 
used for fluorescence staining. Samples were stained with 3 µM 4',6-diamidino-2-phenylindole 
dihydrochloride (DAPI, Sigma, USA) for the nucleus and 10 µM SKDOORLGLQ (Invitrogen Life 
Technologies, USA) for the F-DFWLQILODPHQWV7KHVDPSOHVZHUHWKHQ observed under a fluorescence 
microscope (Olympus, Japan).  
2.9 Reverse Transcriptase and Quantitative Real-Time PCR 
The total RNA of the cells was H[WUDFWHG using the Trizol reagent (Invitrogen, USA) following the 
PDQXIDFWXUHU¶VSURFHGXUH. Samples with 2 µg total RNA were reverse transcribed using the M-MLV 
Reverse Transcription kit with an oligo (dT) 18 primer (TaKaRa Company, Dalian, China). PCR 
amplification was carried out in a volume of 25 µL, which contained 200 ng cDNA, 20 µM each of 
the forward and reverse primers (Glyceraldehyde phosphate dehydrogenase [GAPDH], Runx2, 
Osterix, alkaline phosphatase [ALP], COL1, osteocalcin [OC], and osteopontin [OPN]), which were 
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designed using Primer 3 software, and 12.5 µL of the Power SYBR Green PCR Master Mix (TaKaRa). 
The real-time PCRF\FOLQJFRQGLWLRQVFRPSULVHGDQLQLWLDOGHQDWXUDWLRQVWHSDW&IRUPLQ 30 
cycles ofVHFRQGVDW&IRUGHQDWXUDWLRQVHFRQGVDW&IRUDQQHDOLQJVHFRQGVDW
&IRUH[WHQVLRQDQGPLQDW&IRUDILQDOH[WHQVLRQ5HODWLYHJHQHH[SUHVVLRQZDVdetected
XVLQJDFRPSDUDWLYH&WPHWKRGíGG&WXVLQJWKHIROORZLQJequation46: 
Relative gene expression = íGG&W (DCt sample - DCt control) 
$VVD\VZHUHFDUULHGRXWLQWULSOLFDWH for each gene. 
2.10 Examination of Bone Regeneration in 5DEELWV 
7RDVVHVVWKHDELOLW\RIWKH&3$+DQG&3VFDIIROGVWRSURPRWHERQHUHJHQHUDWLRQLQDFULWLFDOVL]HG
GHIHFWPPUDEELW UDGLXVGHIHFWPRGHOZDVXVHGPDOH-DSDQHVHZKLWH UDEELWV  LQ WRWDO
PRQWKVROGZHLJKWNJZHUHXVHGLQWKHVWXG\DQGZHUHGLYLGHGLQWRWKUHHJURXSVGHIHFW
FRQWURO &3 DQG &3$+$OO DQLPDOV were anesthetized by intravenous injection of SHQWREDUELWDO
VRGLXPP/NJ7KHERWKUDGLXVERQHZDVH[SRVHGZLWKDVWUDLJKWLQFLVLRQDSSUR[LPDWHO\FP
LQ OHQJWKDORQJWKHIRUHDUPERQHDQGPPGHIHFWVZHUHPDGHLQWKHELODWHUDOUDGLXVXVLQJDQ
HOHFWULFGULOO%RQHGHEULVZDVUHPRYHGZLWKSK\VLRORJLFVDOLQH LUULJDWLRQ7KHUDGLXVGHIHFWVZHUH
WKHQLPSODQWHGZLWK&3RU&3$+VFDIIROGV&3DQG&3$+JURXSVZLWKWKHVFDIIROGVIL[HGto the
ulnaXVLQJabsorbable sutures. InWKHFRQWUROJURXSQRVFDIIROGVZHUHLPSODQWHGLQWKHGHIHFWV7KH
ZRXQGVZHUHWKHQVXWXUHG7RSUHYHQWSRVWRSHUDWLYHLQIHFWLRQVSHQLFLOOLQLQMHFWLRQVNXQLWVZHUH
DGPLQLVWHUHGonce a day for 7 days7KHJHQHUDOFRQGLWLRQVRIWKHUDEELWVGLHWDFWLYLW\HQHUJ\DQG
ZRXQGKHDOLQJZHUHFRQWLQXRXVO\PRQLWRUHGIRUZHHNV7KHIROORZLQJH[SHULPHQWVZHUHFDUULHG
RXWDWDQGZHHNVDIWHUVXUJHU\UHVSHFWLYHO\ 
2.11 Radiological Monitoring 
Radiography was performed to identify new bone regeneration during the healing process. Images 
were captured at 4, 8, and 12 weeks after surgery using X-ray machine )D[LWURQ0;86$. 
Images were obtained at 45 Kv and at 3 to 5 mAs. Evidence of callus formation and bone healing in 
the area of defects was also assessed.  
2.12 Micro-CT Scan 
$IWHUradiographic examination, the rabbits were euthanized with an overdose of pentobarbital. The 
soft tissues attached to the bone defects were removed and the tibias were harvested and fixed in 
10%IRUPDOGHK\GHIRU48 h. The tibias were scanned using Micro-computed tomography (micro-CT) 
(GE Healthcare, USA) ZLWKWKHIROORZLQJSDUDPHWHUVYR[HOUHVROXWLRQRI(?PZLWKDQLQWHJUDWLRQ
WLPHRI(?PVDW(?NH9ZLWK(?$FXUUHQWMicro-CTVRIWZDUHZDVXVHGWRtransformed into 3D 
images and measureWKHERQHPLQHUDOGHQVLW\ of new bones. UDEELWVLQHDFKJURXSZHUHFKRVHWR
VFDQ at 4, 8, and 12 weeks after surgeryHDFKVDPSOHZDVVFDQQHGWLPHV, and the DPRXQW of 
bone regeneration was calculated based on the average value. 
+LVWRORJLFDODQG,PPXQRKLVWRFKHPLFDO6WDLQLQJ 
 
  
Tibias were fixed in 10% formaldehyde for 3 days and were then decalcified in 5% EDTA at room 
temperature (pH = 7.0) for 5 weeks. After complete decalcification, the bone specimens were 
dehydrated in ascending ethanol and then embedded in paraffin. The paraffin blocks were sectioned 
into 5 µm thicknesses, stained with H&E and Masson staining, and analyzed with a microscope 
(Olympus, Japan). The quantity of new bone area ratio was assessed using Image-Pro Plus 6.0 
software (Media Cybernetics, Rockville, MD, USA). For immunohistochemical analysis, the sections 
were deparaffinized and then rehydrated by boiling them for 10 min in a sodium citrate solution. The 
following protocols were performed according to the manual of the immunohistochemical kit: 
Sections were treated with several primary antibodies: rabbit monoclonal ALP antibody (1:1000, 
overnight at 4°C; Abcam, USA), rabbit monoclonal COL1 (1:1000, overnight at 4°C; Abcam, USA), 
rabbit monoclonal type 2 collagen (COL2) (1:1000, overnight at 4°C; Abcam, USA), (1:1000, 
overnight at 4°C; Abcam, USA), and rabbit monoclonal OPN antibody (1:1000, overnight at 4°C; 
Abcam, USA); and then with a biotinylated goat anti-mouse or anti-rabbit secondary antibody for 30 
minutes. Sections were stained with 3,¶-diaminobenzidine tetrahydrochloride (DAB; Sigma, USA), 
rinsed with PBS, dehydrated, and examined with a microscope (Olympus). All histological and 
immunohistochemical images were photographed digitally with a microscope and analyzed with a 
digital image analysis system (DXM 1200, Nikon, Japan).  
2.14 Study Approval 
$OODQLPDOH[SHULPHQWVLQWKLVVWXG\ZHUHDSSURYHGE\&KLQD¶V$QLPDO5HVHDUFK$XWKRULW\DQG(WKLFV
Committee of the General Hospital of Lanzhou Military Command of the PLA. AOODQLPDOVWXGLHVZHUH
SHUIRUPHGLQFRPSOLDQFHZLWKWKHUHJXODWLRQVDQGJXLGHOLQHVRIWKH2UWKRSHGLFVGHSDUWPHQWRIWKH
*HQHUDO +RVSLWDO RI /DQ]KRX 0LOLWDU\ &RPPDQG RI WKH 3/$ DQG DQLPDO FDUH ZDV FRQGXFWHG
DFFRUGLQJ WR WKH $VVRFLDWLRQ IRU $VVHVVPHQW DQG $FFUHGLWDWLRQ RI /DERUDWRU\ $QLPDO &DUH
LQWHUQDWLRQDO$$$/$&DQG,QVWLWXWLRQDO$QLPDO&DUHDQG8VH&RPPLWWHH,$&8&JXLGHOLQHV 
2.15 Statistical Analyses 
All data are presented as means ± standard deviations. A two-tailed unpaired 6WXGHQW¶V t test was 
used to assess for significant differences between groups; P value < 0.05 was considered statistically 
significant.6366VWDWLVWLFDOVRIWZDUH636686$ZDVXVHGWRDQDO\]HDOOGDWD  
 
3. 5(68/76 
Morphology and Chemical Composition of the ATP and CPA Scaffolds 
SEM measurements were carried out to reveal the morphology of the ATP, COL1/PCL (CP) and 
COL1/PCL/ATP (CPA) scaffolds with the data shown in Figure 1. ATP (Figure 1A) showed clusters 
of single rod structure with relatively smooth surfaces. The approximate length of the ATP rods was 
0.2 to 1.8 µm with the diameter range from 15 to 50 nm. ATP was found composed of SiO2 (33.7%), 
MgO (9.0%), Al2O3 (5.6%), Fe2O3 (4.1%), CaO (1.5%), KBr (1.3%), and Ti (0.5%) (Figure 1Ac). 
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Figure1B shows the SEM micrographs of CP and CPA scaffolds. The scaffolds showed porous 
structures, ZLWKSRUHVL]HVUDQJLQJIURP 250 to 500 ȝm,ZKLFKwere created by the VRGLXPFKORULGH 
particles. This porosity was beneficial for nutrient exchange and cell migration. Figure 1CVKRZVWKH
FKHPLFDOFRPSRVLWLRQRIWKHCPA-H scaffolds.6WURQJVLJQDOVZHUHGHWHFWHGIRU6L0J$ODQG)H
LQGLFDWLQJ WKHSUHVHQFHRI$73 LQ WKHVFDIIROGV With an increase in ATP, Si was also increased 
(Figure S1), indicatingWKHH[LVWHQFHRIDQ6LFRQWDLQLQJPDWHULDO LQWKHscaffolds$VWURQJFDUERQ
VLJQDOZDVDOVRGHWHFWHGLQWKHCPA scaffolds 
 
)LJXUH$6XUIDFHWRSRJUDSK\RIDWWDSXOJLWH$73D	EZLWKWKHHOHPHQWDOFRPSRVLWLRQRI$73
VKRZQLQF% SEM micrographs of the surface topography of CP, CPA-low dose (CPA-L), and 
CPA high-dose (CPA-H) scaffolds. (C) Distribution of the elemental composition of the CPA±H 
scaffold. 
3.2 Characterization of the scaffolds:3RURVLW\ZDWHUDEVRUSWLRQFRQWDFWDQJOHGHJUDGDELOLW\
mechanical properties, and FTIR study  
The CPA-H scaffold with and without cross-linking were observed under SEM. Higher porosity was 
observed in CPA scaffolds that were not cross-linked (Figure 2A). When the scaffold was cross-
linked by EDC/NHS, the structure became more compacted (Figure 2B) with decreased porosity. 
+RZHYHUDIWHUFURVVOLQNLQJWhe porosity values for CP (87.7%), CPA-L (82.9%) and CPA-H (82.9%) 
were very similar (Figure 2C). The addition of the ATP only resulted in small decrease of the porosity. 
The water absorption values for the cross-linked scaffolds are shown in Figure 2D. The water 
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absorption values decreased from 281.7% for CP to 234.9% for CPA-L and 150.7% for CPA-H, 
indicating that the water absorption capacity of the scaffolds decreased with increasing ATP 
concentration. The was due to the fact that ATP has less water adsorption ability. The contact angles 
(shown in Figure 2E) of the scaffolds were 76° for CP, 57.3° for CPA-L and 42.5° for CPA-H. These 
data suggest that the contact angle of the scaffolds was decreased when the amount of ATP was 
increased. Figure 3FVKRZVWKHGHJUDGDELOLW\RIWKHFURVVOLQNHGVFDIIROGVDIWHULPPHUVLRQLQ3%6
VROXWLRQ$IWHUEHLQJVRDNHGIRUZHHNVWKHCPA-H, CPA-L, and CPVFDIIROGVGHPRQVWUDWHGZHLJKW
ORVV YDOXHV RI   DQG  UHVSHFWLYHO\ VXJJHVWLQJ WKDW WKH GHJUDGDELOLW\ RI WKH
VFDIIROGVZDVGHFUHDVHGZKHQWKHDPRXQWRI$73ZDVLQFUHDVHG 
 
)LJXUH  Characterization of the CP and CPA scaffolds. $ 	 % 6(0 PLFURJUDSKV of CPA-H
VFDIIROGVZLWK%DQGZLWKRXW$FURVVOLQNLQJ&3RURVLW\'ZDWHUDEVRUSWLRQ(FRQWDFWDQJOH
DQG)GHJUDGDELOLW\RIWKH&3DQG&3$VFDIIROGV*. Mechanical properties of the CP and CPA 
scaffolds. (G & I) 6WUHVVVWUDLQFXUYHVIURPWKH3-point bend test of the CP and CPA scaffolds. (H & 
J) 6WUHVVVWUDLQFXUYHV IURP WKHcompression test of the CP and CPA scaffolds. (K) 6WUHVVVWUDLQ
FXUYHVIURPWKHcompression test of the CP and CPA scaffolds on wet condition./)7,5VSHFWUDRI
WKH&3&3$/DQG&3$+VFDIIROGVData are shown as mean ± standard deviation (n = 4). * P < 
0.05; ** P < 0.01.  
7KH stress-strain curves from WKH3-point bend test are shown in Figure 2G and 2I. The average 
tensile strengths of the uncross-linked CPA scaffolds were 20.0MPa for CPA-H and 
 MPa for CPA-L, higher than the tensile strength of the uncross-linked CP scaffolds ( 
MPa) (Figure 2G).0HDQZKLOH the average tensile strength of the cross-linked CPA-H scaffolds was 
MPa, higher than the tensile strengths of the cross-linked CPA-L scaffolds ( 
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MPa) and the cross-linked CP scaffolds (MPa) (Figure 2I). These data demonstrated that 
both addition of ATP and cross-linking of the scaffolds increased the tensile strength of the scaffolds. 
Figure 2H and 2JVKRZWKHcompressive strength of the scaffolds. The average compressive strength 
of the uncross-linked CPA scaffolds was MPa for CPA-H and  MPa for CPA-L, 
higher than the compressive strength of the uncross-linked CP scaffolds (   MPa). The 
average compressive strength of the cross-linked CPA-H scaffolds was MPa, higher than 
the compressive strengths of the cross-linked CPA-L scaffolds ( MPa) and the cross-linked 
CP scaffolds ( MPa). On the wet condition, the average compressive strength of the cross-
linked CPA-H scaffolds was MPa, higher than the compressive strengths of the cross-linked 
CPA-L scaffolds ( MPa) and the cross-linked CP scaffolds ( MPa).These results 
demonstrated that both addition of ATP and cross-linking of the scaffolds increased the compressive 
strength of the scaffolds. 
The )7,5 spectra of the scaffolds are shown in Figure 2L. The spectra of the CPA scaffolds 
demonstrated a typical and predominantly antisymmetrical stretching vibration peak at  cm-1, 
representing the 6L26L bond of the CPA scaffolds. A symmetrical stretching vibration representing 
the Si-O vibrational peak at 800 cm-1 was also observed. Peaks that occurred at FPDQG
cm-1 represented amide A and amide I from collagen in both the CP and CPA scaffolds. In the CPA 
scaffolds, amide I and amide II appeared as peaks at  cm-1 and FP representing C=O 
and N-H stretching RIWKHcollagenSRO\HWKHU peaks, respectively.  
 
3.3 Cell Morphology$GKHVLRQDQG3UROLIHUDWLRQ on the Scaffolds 
)LJXUHVKRZVWKHCRL-12424) FHOOPRUSKRORJ\DGKHVLRQDQGSUROLIHUDWLRQRQWKHVFDIIROGV$IWHU
 GD\V RI FXOWXULQJ D VPDOO QXPEHU RI FHOOV ZDV REVHUYHG RQ WKH CP VFDIIROGV ZKHUHDV ODUJH
QXPEHUVRIFHOOVZHUHREVHUYHGRQWKH&3$/DQG&3$+VFDIIROGV$WGD\WKHFHOOSRSXODWLRQ
GHQVLW\LQFUHDVHGIRUDOOWKHVFDIIROGVDQGWKHGHSRVLWLRQRIH[WUDFHOOXODUPDWUL[(&0ZDVREVHUYHG
RQWKHERWK&3$/DQG&3$+VFDIIROGV'XULQJWKHVDPHWLPHSHULRGDYHU\KLJKFHOOGHQVLW\ZDV
REVHUYHGRQWKH&3$+VFDIIROGVXUIDFH7KHFHOOVZHUHPRUHHORQJDWHGRQ&3$+VFDIIROGVXUIDFH
7KHSRUHVRQWKHVFDIIROGZHUHFRYHUHGE\WKHFHOOVDQG(&0VHFUHWHGIURPWKHFHOOV,QDGGLWLRQD
FU\VWDOOLNH(&0VWUXFWXUHZDVREVHUYHGRQWKHORZHUULJKWVLGHRIWKH&3$+VFDIIROGV (Figure 3$)
,mmunofluorescence staining Figure 3B) indicated substantially higher cell numbers on the CPA 
scaffolds than that on the CPVFDIIROGVDWGD\VDIWHULQRFXODWLRQ  
CCK-8 assay was performed to evaluate the cell proliferation of CRL-10915 FHOOVRQVFDIIROGVZLWK
WKHGDWDVKRZQLQ)LJXUH& No significant difference in cell proliferation was seen for the CPA and 
CP scaffolds at day 1. At day 3, clear differences were observed. Cell proliferation increased with 
the increasing amount of ATP in the scaffolds. By day 7, cell proliferation on the CPA-H scaffolds 
was remarkably increased when compared with cell proliferation on the CPA-L and CP scaffolds.  
 
  
 
)LJXUHAdhesion, proliferation and Osteogenic differentiation of D1 cells on the CP and CPA 
scaffolds. (A) SEM images of cell adhesion and proliferation at 3 and 7 days on the scaffolds. (B) 
Immunofluorescence staining of cell adhesion and proliferation on the scaffolds at day 7.5HG 
VFDIIROGEOXH nucleusJUHHQ )DFWLQ&&HOOSUROLIHUDWLRQRQ WKHVFDIIROGVDVVHVVHGE\ Cell 
Counting Kit-8 assay. (D-I) mRNA expression assays of bone tissue-specific markers: (D) Runx2, 
(E) Osterix, (F) alkaline phosphatase (ALP), (G) collagen type 1 (COL1), (H) osteocalcin (OC), and 
(I) RVWHRSRQWLQ (OPN). Data are shown as mean ± standard deviation (n = 3). Red arrow= cells; Blue 
arrow= extracellular matrix (ECM). Scale bars = 100 µm. * P < 0.05; ** P < 0.01; # P < 0.05; ƷP<0.05. 
3.4 Expression of Osteoblast Molecular Markers  
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Osteoblast molecular markers are important indicators for bone regeneration. Figure 3D-I show the 
mRNA expression of bone tissue-specific markers between 7-21 days. After 7 days of incubation, 
the expression level of Runx2 mRNA was notably increased in cells implanted on the CPA scaffolds 
versus those implanted on the CP scaffolds. The expression level of Runx2 rapidly decreased after 
14 and 21 days in cells on the CPA scaffold (Figure 3D) indicating the differentiation of the 
multipotent mesenchymal precursor cells into osteoblasts. The mRNA expression level of Osterix 
(Figure 3E) of CPA-L and CPA-H scaffolds were lower than that of CP scaffolds at day 7. However, 
it gradually increased with time and the concentration of ATP. At day 21, the mRNA expression level 
of Osterix was significantly higher than that of CP and CPA-L scaffolds. Similar trends were observed 
for the mRNA expression levels of COL1 (Figure 3G), OPN (Figure 3H) and OC (Figure 3I). For the 
mRNA expression level of ALP, the expression level was low for CP scaffold, but significantly 
increased with time and the increased percentage of ATP (Figure 3F). 
 
3.5 Implantation Procedure, Radiographic Examination and Micro-CT Scan 
The CP and CPA-H scaffolds were implanted into 15 mm rabbit radius defect model with the 
implantation procedure shown in Figure 4A. X-ray experiments were performed at 4, 8, 12 weeks 
after implantation (Figure 4B). Postoperative radiographs demonstrated that clear defects can be 
observed at the implants¶ areas at week 4. However, some low-density developments were also 
observed in the bone defect areas. The bone regeneration of CPA-H is better than CPA-L and CP. 
At week 8, defects can still be seen in CP scaffold areas, while in CPA scaffold areas, the defects 
were filled in with low density new bone. At week 12, all the defects were filled in with CPA scaffolds 
have higher density bone. In the CPA-H group, a bone marrow cavity formed in the newly formed 
bone by week 12 (Figure 4B). 
Figure 4C shows the Micro-CT scan results of the scaffold areas. At 4 weeks, a small amount of 
ERQHOLNH WLVVXH was observed within the bone defect area in the CPVFDIIROG group (Figure 4C). 
However, the tissue mineral content was markedly lower LQWKLVJURXSWKDQWKDWLQWKH CPA-H scaffold 
group (Figure 4D). After 8 weeks, ERQHOLNHWLVVXH was observed in the CPA-H and CP groups, but 
the bone observed in the CP group was discontinuous. In addition, the tissue mineral content of the 
bone defect area was markedly lower in the CP group than that in the CPA-H group. A large amount 
of new ERQHOLNHWLVVXH was observed in the bone defect area of the CPA-HVFDIIROG group at 12 
weeks after transplantation. The tissue mineral content was remarkably increased in the CPA-H 
scaffold versus the control group. The tissue mineral content showed a dose and time dependent 
manner (Figure 4D). The more ATP presented in the scaffolds the higher tissue mineral content was 
detected. The tissue mineral content also increases with postoperative time.     
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)LJXUH  Implantation procedure, X-ray and micro-CT analysis of new bone. (A) Photographs 
showing the surgical implantation procedure for CP and CPA-H scaffolds in rabbit bone. 
Representative radiographs (B) and Micro-CT images (C) showing the level of regenerated bone 
tissue after 4-12 weeks. (D) Tissue mineral content of the regenerated bone tissue after 4-12 weeks. 
Data are shown as mean ± standard deviation (n = 3). CPA-H = CPA high-dose. * P < 0.05; ** P < 
0.01; # P < 0.05; ## P < 0.01.  
 
3.6 New Bone Formation Assessed by Histologic Analysis 
Histologic Analysis was performed at week 4, 8, and 12 to evaluate the new bone formation with 
data shown in Figure 5. Four weeks after transplantation, monocytes, plasma cells, and lymphocytes 
were observed within all implant scaffolds. At week 8, the presence of fibrous connective tissue was 
seen in the control group. In the CP group, the scaffold materials partially disappeared, and more 
fibrous connective tissue grew into the scaffolds, indicating the degradation of the scaffolds was 
faster than the desired degradation rate. In contrast, new bone was observed in the CPA-H scaffold 
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group. At week 12, most of the area of bone defect was covered by fibrous connective tissue in the 
control group, indicating that new bone had not been formed. In the CP group, the scaffold was 
completely replaced by fibrous tissue. In contrast, in the CPA-H group, new bone formation was 
observed around the scaffold area. The original shape of the implant scaffolds had gradually 
disappeared and was visible only in the center of the scaffolds (Figures 5A and 5C). 
 
)LJXUH Histological staining of the newly formed bone 4-12 weeks after implantation of CP and 
CPA-H scaffolds in rabbit bone defects. (A) Hematoxylin and eosin (H&E) staining. (B) Masson 
staining. &	'VKRZWKHTXDQWLWDWLYHGDWDIURP$	%UHVSHFWLYHO\ Scale bar = 100 µm. F = 
fibrous tissue; HB = host bone; IM = implanted material; NB = new bone. * P < 0.05, ** P < 0.01, *** 
P < 0.01, # P < 0.05, ## P < 0.01. 
Masson staining (Figure 5B) demonstrated that the control group had fibrous tissue at the bone 
defect area 4 weeks after transplantation. The fibrous tissue filled in the central portion of the defect 
area. On the other hand, the reconnected fibrous tissue and small areas of bone-like tissue had been 
found in the defect bone in the CPDQGCPA-HVFDIIROG groups. In the CPA-H group, single bone 
fragments were observed 8 weeks after scaffold implantation. At 12 weeks, abundant new bone 
formation was seen in the center of the CPA-H scaffolds, but CPA-H materials had not been 
completely absorbed (Figures 5B and 5D).  
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)LJXUH Immunohistochemical staining of the newly formed bone 4-12 weeks after implantation of 
CP and CPA-H scaffolds in rabbit bone defects.$&(DQG*Immunohistochemical staining for 
(A) alkaline phosphatase (ALP), (C) type 1 collagen (COL1), (E) type 2 collagen (COL2), and*
RVWHRSRQWLQ (OPN). (B, D, F, and H)VKRZQWKHTXDQWLWDWLYHGDWDIURP$&(DQG*UHVSHFWLYHO\ 
Data are shown as mean ± standard deviation (n = 6). Scale bar = 100 µm. * P < 0.05, ** P < 0.01, 
*** P < 0.01, # P < 0.05, ## P < 0.01. 
 
3.7 Immunohistochemical Assessment 
The data of immunohistochemical assessment are shown in Figure 6. Four weeks after implantation, 
positive expression of ALP, COL1, COL2, and OPN was observed in all three groups. For ALP, 
COL2 and OPN, the expression levels showed the time and ATP dose dependent effects for all three 
groups, while the expression levels in CPA-H scaffolds were higher than that in CP scaffolds and 
control group. For COL1, high expression was observed in control group. The level of expression 
was found similar between 4-12 weeks. In CP group, COL1 expression increased with time, while in 
CPA-H group, COL1 expression increased with time and leveled off at week 12. The high expression 
of COL1 in control demonstrated the presence of cartilage tissue within the control group, indicating 
that the bone regeneration was not good. The intensity of positive staining for ALP, COL1 COL2 and 
OPN in the CPA-H scaffolds increased over time. This expression was mainly seen in the border of 
the new bone. The results demonstrate that in the control group the new tissue formed was mainly 
fibrous tissue containing a lot of collagen type 1. While in the CP and CPA-H groups, new bone 
tissues were formed and the amount of new bone in CPA-H group was much higher than that in CP 
group.   
 
4. DISCUSSION 
,Q WKLV ZRUN ZH LQYHVWLJDWHG WKH ERQH UHJHQHUDWLRQ HIILFDF\ RI WKH &3$ FRPSRVLWH VFDIIROGV IRU
VHJPHQWDOERQHGHIHFWKHDOLQJ2XUUHVXOWVVKRZWKDWWKHZDWHUDEVRUSWLRQSRURVLW\FRQWDFWDQJOH
DQG GHJUDGDWLRQ RI WKH VFDIIROGV ZHUH LPSURYHG ZLWK LQFUHDVLQJ $73 FRQWHQW 3RUH VL]HV DUH
LPSRUWDQWIRU%7(VFDIIROGVDQGKDVEHHQVKRZQWRDIIHFWWKHSURJUHVVLRQRIRVWHRJHQHVLV6PDOO
SRUHVL]HVPQRWRQO\UHGXFHFHOOPLJUDWLRQEXWDOVRUHVWULFWQXWULHQWGHOLYHU\DQGZDVWH
UHPRYDO$GGLWLRQDOO\LWDOVROLPLWWKHDPRXQWRIQHZWLVVXHUHJHQHUDWLRQ,WKDVEHHQUHSRUWHGWKDW
SRUHVL]HV!PZLWKJUDGLHQWVDUHUHFRPPHQGHG,QRXUVWXG\WKH&3DQG&3$FRPSRVLWH
VFDIIROGVZHUH IDEULFDWHG E\ VDOWOHDFKLQJPHWKRG7KHVFDIIROGV VKRZHGSRURXVVWUXFWXUHVZLWK
SRUHVL]HVUDQJLQJIURPWRȝPZKLFKwere created by the VRGLXPFKORULGH particles. This 
porosity was beneficial for nutrient exchange, cell migration, and bone regeneration. 
,GHDOO\ELRPDWHULDOVLPSODQWVIRUFOLQLFDODSSOLFDWLRQVVKRXOGPDWFKWKHPHFKDQLFDOSURSHUWLHVRIWKH
KRVWWLVVXHDQGH[KLELWVWURQJ LQWHUIDFLDOERQGVZLWKKDUGDQGRUVRIW WLVVXHV+RZHYHU WKHPDMRU
GLVDGYDQWDJHV RI WKH LQRUJDQLF DQG RUJDQLF FRPSRQHQW DUH WKHLU ORZ PHFKDQLFDO VWUHQJWK DQG
 
  
IUDFWXUHWRXJKQHVVZKLFKW\SLFDOO\UHVWULFWWKHLUXVHERQHWLVVXHHQJLQHHULQJ2XUUHVXOWVVKRZHG
WKDW KLJKHU FRQFHQWUDWLRQ RI $73 DOVR OHG WR LQFUHDVHG FRPSUHVVLYH VWUHQJWK VXJJHVWLQJ WKDW
LQFUHDVHG$73 OHDGV WR LPSURYHG PHFKDQLFDO VWUHQJWK 7KH$73 FDQ SURYLGH ERWK VWUHQJWK DQG
ELRDFWLYLW\ ZKLOH WKH FROODJHQ FDQ DGG VWUXFWXUDO UHLQIRUFHPHQW DQG WRXJKQHVV7KH PHFKDQLFDO
VWUHQJWKRI WKH&3$FRPSRVLWHVFDIIROGV LV ORZHU WKDQWKDWRI WKHQDWXUDOERQH ,Q WKH IXWXUHRXU
VWUDWHJLHVDUHWRSURGXFHHQKDQFHGFRPSRVLWHVDQGXVHQRYHOIDEULFDWLRQPHWKRGVHJ'SULQWLQJ
WRRYHUFRPHWKLVGUDZEDFN 
Cytocompatibility of the biomaterials used in scaffolds plays a vital role in sustaining cell adhesion, 
proliferation, and differentiation and in enabling tissue regeneration after implantation49. In this study, 
the CPA scaffolds promoted colony morphology and induced cell proliferation when they were 
cocultured with cells for 1 to 7 days. The proliferation rate of cells on the CPA-H scaffold was 
significantly higher than the rate on the CPA-L and CP scaffolds after 7 days, suggesting that CPA 
scaffolds induce the proliferation of cells in a dose-dependent manner and the addition of ATP has 
significant effect to the cell growth. 7KHVHUHVXOWVDUHFRQVLVWHQWWRWKHUHVXOWVUHSRUWHGE\:DQJHW
DOZKRIRXQGWKDWWKHGRSLQJRI$73ZLWKLQWKH3/*$QDQRILEHUVLVDEOHWRLQGXFHWKHRVWHREODVWLF
GLIIHUHQWLDWLRQ RI K06&V 2XU UHVXOWV DOVR GHPRQVWUDWH WKDW &3$ VFDIIROG FDQ LQFUHDVH WKH FHOO
SUROLIHUDWLRQDQGSURPRWHosteoblasts related gene expression, WKHUHIRUH increase bone regeneration.   
An immunofluorescence assay demonstrated that D1 cells was able to proliferate and migrate in the 
interior of the CPA scaffolds. Additionally, in vivo studies in a rat model demonstrated no evidence 
of severe immune response or fibrous capsule formation with the CPA scaffolds, suggesting good 
biocompatibility. The D1 cells grown on CPA scaffolds had upregulated levels of osteoblastic 
markers, including upregulated levels of Runx2 at day 7 and Osterix at day 21. These results suggest 
that D1 cells can differentiate into osteoblasts on CPA scaffolds. We also found that the expressions 
of COL1, ALP, OC, and OPN were significantly higher on CPA scaffolds than that on CP scaffolds, 
and this increased expression occurred in a dose-dependent and time-dependent manner. These in 
vitro findings suggest that CPA has VWURQJRVWHRLQGXFWLYHSURSHUWLHVCPA may promote D1 cell 
osteoblast differentiation through several mechanisms: i), The elements from ATP (SiO2, Al2O3, MgO, 
Fe2O3, H2O+, and H2Oí), especially SiO2, can induce D1 cells to differentiate into osteoblasts1. ii), 
ATP has desired physical properties, such as larger specific surface area, high viscosity, and high 
absorption ability, that make this mineral osteoinductive. iii), the synergistic effect between the 
chemical and physical properties of ATP may induce D1 cells to differentiate into osteoblasts.  
'XULQJWKHLQYLYRERQHWLVVXHVIRUPDWLRQWKHELRPDWHULDOVKRXOGGHJUDGHVORZO\WRPDWFKWKHperfect 
restoration of the ERQHGHIHFW,QWKHUDEELWPRGHOZHXVHGLQWKLVVWXG\ a large amount of bone 
mass was observed in the CPA scaffold groups at weeks 8 and 12. This was especially obvious in 
the scaffold that contained CPA-H, in which the bone mass completely filled in the bony defect at 
week 12. IPPXQRKLVWRFKHPLFDO analysis also demonstrated remarkable increase in the expression 
of ALP, COL1, COL2, and OPN in the CPA scaffolds versus in the CP scaffolds at weeks 8 and 12. 
These findings again suggest that ATP was able to induce the formation of vital bony structures. 
While the ATP has not yet been widely used in tissue engineering, this study opens a door for ATP 
 
  
as a promising material for tissue engineering applications.   
 
5.  &21&/86,216 
6DOW OHDFKLQJ LV DQ effective PHWKRG RI VFDIIROG IDEULFDWLRQ WKDW KDV EHHQ XVHG WR FUHDWH WKH
macroporousVFDIIROGVQHHGHGIRUERQHWLVVXHHQJLQHHULQJ,QWKLVVWXG\ZHXVHGWKHVDOWOHDFKLQJ
PHWKRGWRIDEULFDWHPDFURPHVRSRURXVVFDIIROGVFRQWDLQLQJHLWKHU&2/3&/RU&2/3&/$73DV
ERQH UHJHQHUDWLRQ PDWHULDOV :H IRXQG WKDW PDFURSRUHV DSSUR[LPDWHO\  ȝP KDG EHHQ
FUHDWHGE\sodium chlorideLQERWKthe CPDQG&3$VFDIIROGVZKLFKLVLPSRUWDQWIRUFHOOLQJURZWK
DQG nutrition delivery. Cross-linking of the collagen with EDC/NHS changed the structure of the 
collagen, which led to changes in porosity and water absorption. Cross-linking improved the 
compressive strength and decreased the porosity of the CPA scaffolds. These results suggest that 
a cross-linked CPA scaffolds are more suitable for BTE. ,QFRQFOXVLRQZHIRXQGWKDWCPA scaffolds 
prepared through a salt-leaching technique were more effective than CP scaffolds in inducing bone 
regeneration. 7KHVH UHVXOWV VXJJHVW WKDW CPA scaffolds, because of their specific physical and 
chemical properties, may have great potential for the induction of bone regeneration and promotion 
of bone repair. Further studies DUHQHHGHGWRDVVHVVWKHXVHRIWKHVHVFDIIROGVLQDFOLQLFDOVHWWLQJ 
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